文献速递肿瘤 PET/CT神经核医学

病理证实的神经鞘瘤的FDG PET/CT与MRI影像特征

FDG PET/CT and MRI Features of Pathologically Proven Schwannomas.
PubMed 文献 · Clin Nucl Med · 2021-01-01

70%同时接受两种检查的病灶至少具备1项通常提示恶性周围神经鞘瘤的影像特征,提示神经鞘瘤可表现高代谢和显著异质性。

要点

  • 神经鞘瘤平均SUVmax为5.4±2.7,35%病灶SUVmax>6.1,15%>8.1。
  • 70%同时行PET和MRI的病灶至少具备1项提示恶性周围神经鞘瘤的影像特征。
  • FDG摄取不均匀的病灶SUVmax更高且MRI内部无强化更常见。

核心结论

  • 神经鞘瘤可体积较大、FDG摄取强烈且表现显著异质性,这些特征通常与恶性周围神经鞘瘤相关。
  • 相当比例的神经鞘瘤FDG活性超过既往用于鉴别良恶性周围神经鞘瘤的截断值。

研究设计与样本

  • 经机构审查委员会批准的回顾性研究,纳入2002年1月1日至2018年4月1日在本机构经活检证实的神经鞘瘤。

主要发现

  • 平均最大径为4.6±2.7 cm,平均SUVmax为5.4±2.7,病灶SUVmax/肝脏SUVmean为2.2±1.2。
  • MRI上29/53(55%)显示内部无强化区。
  • FDG摄取不均匀的病灶SUVmax更高(6.5±0.5 vs 4.7±0.4,P=0.0031),且MRI内部无强化更频繁(P=0.0218)。

关键数值与推荐

  • SUVmax>8.1、SUVmax>6.1和病灶SUVmax/肝脏SUVmean>3.0的阈值及对应比例按原文报告。
  • 提示恶性周围神经鞘瘤的影像特征包括边缘不规则、内部无强化、瘤周水肿、FDG摄取不均匀或SUVmax>8.1。

临床怎么用

  • 神经鞘瘤可表现高FDG摄取和异质性,解读PET/CT时需注意其可与恶性周围神经鞘瘤特征重叠。
  • 对于具备边缘不规则、内部无强化、瘤周水肿、FDG摄取不均匀或SUVmax>8.1等特征的病灶,应结合病理谨慎鉴别。

局限性

  • 回顾性单中心研究,部分病灶仅有PET或仅有MRI数据。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to examine the MRI and FDG PET/CT imaging features of pathologically proven schwannomas. PATIENTS AND METHODS: This institutional review board-approved retrospective study examined biopsy-proven schwannomas that underwent FDG PET/CT and/or MRI at our institution between January 1, 2002, and April 1, 2018. PET/CT features analyzed included SUVmax, metabolic ratios, volumetric metabolic measures, presence of calcification, and pattern of FDG activity. MRI features included T1/T2 signal, enhancement pattern, margins, perilesional edema, presence of muscular denervation, and size. RESULTS: Ninety-five biopsy-proven schwannomas were identified (40 with both PET and MRI, 35 with PET only, and 20 with MRI only), 46 females and 49 males, average age of 57.7 ± 15.3 years. The average largest dimension was 4.6 ± 2.7 cm, the average SUVmax was 5.4 ± 2.7, and lesion SUVmax/liver SUVmean was 2.2 ± 1.2. Eleven (15%) of 75 lesions had SUVmax greater than 8.1, 26/75 (35%) had SUVmax greater than 6.1, and 14/75 (19%) had lesion SUVmax/liver SUVmean greater than 3.0. On MRI, 29/53 (55%) demonstrated internal nonenhancing areas. Twenty-eight (70%) of 40 lesions with both MRI and PET demonstrated at least 1 imaging feature concerning for malignant peripheral nerve sheath tumor (irregular margins, internal nonenhancement, perilesional edema, heterogeneous FDG uptake, or SUVmax >8.1). Lesions with heterogeneous FDG activity had higher SUVmax (6.5 ± 0.5 vs 4.7 ± 0.4, P = 0.0031) and more frequent internal nonenhancement on MRI (P = 0.0218). CONCLUSIONS: Schwannomas may be large, be intensely FDG avid, and demonstrate significant heterogeneity, features typically associated with malignant peripheral nerve sheath tumors. A significant proportion exhibit FDG activity above cutoff levels previously thought useful in differentiating malignant from benign peripheral nerve sheath tumors.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Dewey BJ, Howe BM, Spinner RJ, et al. FDG PET/CT and MRI Features of Pathologically Proven Schwannomas. Clin Nucl Med. 2021. PMID: 33443952. doi:10.1097/RLU.0000000000003485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。